barriers to treatment
Hepatitis C (HCV) can only be eradicated if annual rates of cure (SVR) are consistently and significantly higher than new HCV infections, across many countries. In 2016, the WHO called for a 90% reduction in new HCV infection by 2030. Direct-acting antivirals (DAA) can cure the majority of those treated, at around 90% in most populations, at potentially very low prices. We compared the net annual change in epidemic size across 91 countries using data on SVR, new HCV infections, and deaths.
High prices of DAAs mean there's been little progress towards achieving WHO target of eliminating HCV by 2030
Health Provider Views on Improving Antiretroviral Therapy Adherence Among Men Who Have Sex with Men in Coastal Kenya
HIV-positive Kenyan men who have sex with men (MSM) are a highly stigmatized group facing barriers to care engagement and antiretroviral therapy (ART) adherence. Because care providers' views are important in improving outcomes, we sought the perspective of those serving MSM patients on how to optimize ART adherence in a setting where same-sex behavior is criminalized. We conducted 4 focus group discussions with a total of 29 healthcare workers (HCWs) experienced in providing HIV care to MSM.
The Stop TB Partnership today launched its World TB Day website which has the full spectrum of downloadable communications materials. World TB Day is organized each year on 24 March and aims to build awareness on TB. It is an opportunity for people everywhere to join the fight against TB, sharing information about TB and urging governments to take action.
Writing in The Lancet, Dr. Stefano Vella, a distinguished HIV researcher and a member of the Governing council of the International AIDS Society, shares his thoughts on what needs to be done to end the HIV epidemic by 2030. The success that has been achieved against the disease in the last two decades, Vella writes, should not mask the challenges that lie ahead. To end the epidemic in the next 15 years, he sees hard work ahead.